by AnTolRx | Aug 21, 2018 | Articles
Dr. Quintana will present an update on his research into the role of the Aryl hydrocarbon Receptor in human health and disease at the 2018 AhR Symposium, held this year in Paris, France from August 28-31st. AnTolRx scientists will also be attending. The meeting will... by AnTolRx | Apr 9, 2018 | Updates
World Vaccine Congress Investor Panel, April 4th “…..Mr Carthy commented that “antigen specific tolerance has the potential to deliver disease modifying therapy for indications including autoimmune, allergies and protein drug antibody reactions. AnTolRx has... by AnTolRx | Jan 23, 2018 | Updates
Dr. Francisco J Quintana will be presenting data on AnTolRx’s antigen-specific nanoparticle platform. Join us in Boston April 24-26, 2018. http://as-immunetolerance.com by AnTolRx | Jan 6, 2018 | Updates
We are excited to attend the 36th annual JP Morgan Healthcare Conference in San Francisco, CA from January 8th-11th,... by AnTolRx | Nov 29, 2016 | Publication
Goettel, J. et al. Cell Rep 17, 1318-1329(2016)